The China Alzheimer Report 2022

Area of Science:

• Public Health
• Epidemiology
• Gerontology

Background:

• China's population is rapidly aging, coinciding with a rise in neurodegenerative disorders like Alzheimer's disease and related dementias (ADRD).
• ADRD is now the fifth leading cause of death in China, imposing significant financial burdens on individuals, families, and society.
• The 'Healthy China Action' plan (2019-2030) emphasizes a shift towards health maintenance for the growing ADRD population.

Purpose of the Study:

• To analyze epidemiological trends of ADRD in China.
• To evaluate the economic burden and public health impact of ADRD.
• To outline current clinical practices, available resources, and policy recommendations for ADRD prevention and treatment.

Main Methods:

• Review of epidemiological data on ADRD prevalence, morbidity, and mortality.
• Economic analysis of ADRD costs, including healthcare utilization and societal impact.
• Assessment of current diagnostic and treatment strategies and public health resource allocation.

Main Results:

• ADRD incidence, morbidity, and mortality rates are increasing in China.
• Significant financial and societal costs associated with ADRD are identified.
• Gaps in current public health resources and policy frameworks for ADRD management are highlighted.

Conclusions:

• Urgent public health interventions are needed to address the escalating challenge of ADRD in China.
• Evidence-based strategies and policy development are crucial for effective ADRD prevention and treatment.
• Enhanced international collaboration and information exchange can support national efforts in combating ADRD.